An essential component of the UF Health Cancer Center’s mission is conducting clinical research that directly impacts patients by delivering new and promising cancer treatments. The Cancer Center’s innovative clinical research, funded in part through the state of Florida, includes developing and implementing cancer clinical trials that bring opportunities for patients in Florida and beyond to access new cancer treatments. This leading-edge research ensures the Cancer Center provides patient care that meets the needs of the rural and diverse population it serves and contributes to advancing scientific progress for future patients.
Bently Doonan, M.D., M.S.
Bently Doonan, M.D., M.S., an assistant professor in the division of hematology and oncology in the UF College of Medicine, is one of the clinical investigators at the Cancer Center who has dedicated his career to developing better treatments for patients with cancer, particularly those with skin and brain cancers.
Erin Dean, M.D.
Erin Dean, M.D., an assistant professor in the division of hematology and oncology in the department of medicine in the UF College of Medicine, is one of the clinical investigators at the Cancer Center who has dedicated her career to developing better treatments for patients with lymphoma and multiple myeloma, particularly those undergoing cellular immunotherapy and stem cell transplantation.
Ilyas Sahin, M.D.
Ilyas Sahin, M.D., an assistant professor in the division of hematology and oncology in the department of medicine in the UF College of Medicine, is one of the clinical investigators at the Cancer Center who has dedicated his career to developing better treatments for patients with gastrointestinal cancer, particularly cancers involving the liver, stomach and esophagus.
Mansi Dalal, M.D.
Mansi Dalal, M.D., an assistant professor in the division of hematology and oncology in the department of pediatrics in the UF College of Medicine, is one of the clinical investigators at the Cancer Center who has dedicated her career to developing better treatments for some of our youngest patients with cancer, particularly those with leukemia and lymphoma.
Brian Ramnaraign, M.D.
Brian Ramnaraign, M.D., an assistant professor in the division of hematology and oncology in the department of medicine in the UF College of Medicine, is one of the clinical investigators at the Cancer Center who has dedicated his career to developing better treatments for patients with cancer, particularly genitourinary cancers and neuroendocrine tumors.
